logo
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty
Adherence to guidelines for the management of excessive warfarin anticoagulation
The smoker's paradox after successful fibrinolysis
Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery
Multilayer compression bandaging in the acute phase of deep-vein thrombosis has no effect on the development of the post-thrombotic syndrome
The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy
Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis
Indications of combined vitamin K antagonists and aspirin therapy
Predictors of unstable anticoagulation in African Americans
Selective thromboxane inhibition after vascular protectant AGI-1067
Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting
Romiplostim
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified
Relationship between Factor XII deficiency and thrombosis
Ischemic neuropathy and rhabdomyolysis as presenting symptoms of postpartum cardiomyopathy
Warfarin in vulnerable older adults with atrial fibrillation